PUT - SPRINTER OPEN END - STRYKER CORP. Stock

Certificat

DE000VM55EG9

Delayed Deutsche Boerse AG 04:16:27 2024-05-23 EDT
7.38 EUR -0.81% Intraday chart for PUT - SPRINTER OPEN END - STRYKER CORP.
Current month+2.34%
1 month-8.49%
Date Price Change
24-05-23 7.38 -0.81%
24-05-22 7.44 -6.65%
24-05-21 7.97 +1.40%
24-05-20 7.86 +3.56%
24-05-17 7.59 +1.20%

Delayed Quote Deutsche Boerse AG

Last update May 23, 2024 at 04:16 am

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellPUT
Underlying STRYKER CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VM55EG
ISINDE000VM55EG9
Date issued 2023-11-29
Strike 414.8 $
Maturity Unlimited
Parity 10 : 1
Emission price 11.47
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 11.8
Lowest since issue 5.11
Spread 0.1
Spread %1.35%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
335.4 USD
Average target price
372.4 USD
Spread / Average Target
+11.01%
Consensus